Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the department of defense (DOD) Center for Prostate Disease Research (CPDR) national database
Judd W. Moul(General Marble (Greece)), Timothy F. Donahue(Memorial Sloan Kettering Cancer Center), Wade J. Sexton(Madigan Army Medical Center), Leon Sun(Madigan Army Medical Center), Christopher L. Amling(Oregon Health & Science University), Andrew Chung(Madigan Army Medical Center), Hongyu Wu(Qingdao University), Raymond Lance(Madigan Army Medical Center), David G. McLeod(George Washington University), Leo Kusuda(Madigan Army Medical Center), John Foley(Princeton University), Douglas W. Soderdahl(Eisenhower Medical Center)
Cited by 26
Related Papers
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy
|The Journal of Urology|2003|293